Bio-Path Holdings

-$0.05 (-0.97%) Today
-$0.01 (-0.20%) As of 11:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BPTH and other ETFs, options, and stocks.

About BPTH

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003.

CEO
Peter H. Nielsen
Employees
10
Headquarters
Bellaire, Texas
Founded
2007

BPTH Key Statistics

Market Cap
35.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
41.72K
High Today
$5.15
Low Today
$5.02
Open Price
$5.14
Volume
50.76K
52 Week High
$24.34
52 Week Low
$3.12

BPTH Earnings

-$0.96
-$0.64
-$0.32
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure